All entries for: NewcelX Ltd.

April 29, 2026

NewcelX Ltd.

Neutral Outlook

Kloten, Switzerland
1-50 employees

It is currently unclear how the IRA will be implemented but is likely to have a significant impact on the pharmaceutical industry.

Disease Area: Endocrinology, Neurological Diseases
Drug Type: Small Molecule
April 29, 2026

NewcelX Ltd.

Neutral Outlook

Kloten, Switzerland
1-50 employees

Additionally, HHS began implementation in 2025 of “Most Favored Nation” drug pricing by setting the Medicare price of single-source brand drugs without generic or biosimilar competition to the lowest price available in wealthy countries with a per capita GDP of at least 60% of that in the United States.

Scroll to Top